Gene therapy against Rett syndrome and functional analysis of MeCP2, using blood-brain barrier-penetrating AAV vectors
Project/Area Number |
18H02521
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Review Section |
Basic Section 46010:Neuroscience-general-related
|
Research Institution | Gunma University |
Principal Investigator |
HIRAI HIROKAZU 群馬大学, 大学院医学系研究科, 教授 (70291086)
|
Project Period (FY) |
2018-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2020)
|
Budget Amount *help |
¥17,290,000 (Direct Cost: ¥13,300,000、Indirect Cost: ¥3,990,000)
Fiscal Year 2020: ¥5,980,000 (Direct Cost: ¥4,600,000、Indirect Cost: ¥1,380,000)
Fiscal Year 2019: ¥5,590,000 (Direct Cost: ¥4,300,000、Indirect Cost: ¥1,290,000)
Fiscal Year 2018: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
|
Keywords | 自閉症 / MeCP2 / AAV / レット症候群 / 小脳 / 細胞種特異的プロモーター / Cre / floxマウス / ウイルスベクター / シナプス可塑性 / プルキンエ細胞 |
Outline of Final Research Achievements |
Rett syndrome and MeCP2 duplication syndrome, which are characterized by various manifestations such as autism and epilepsy, are caused by mutation of MeCP2 gene. MeCP2 is critical for brain development in both neurons and astrocytes. In this study, we examined which MeCP2 in neurons or in astrocytes is critical for brain function of mature mice. We found that overexpression of MeCP2 in astrocytes caused no abnormal phenotypes, while overexpression in neurons induced impaired social behavior. In addition, we succeeded to knockout MeCP2 gene from mature mouse cerebellar neurons.
|
Academic Significance and Societal Importance of the Research Achievements |
MeCP2はニューロンとアストロサイトの両方で、脳の発達に重要な役割を果たすことが知られている。しかし、MeCP2は成熟後も脳で発現し続けるが、成熟脳における役割はほとんど明らかになっていない。本研究で、成熟マウスのニューロンにMeCP2を過剰発現させると他のマウスにあまり関心を示さなくなった。すなわち、ニューロンに発現するMeCP2は他者とコミュニケーションをとる社会行動に重要な役割を果たすことが示唆された。
|
Report
(4 results)
Research Products
(20 results)